U.S. Government Engages Dx Firms For Rapid, Field-Based Ebola Test
This article was originally published in The Gray Sheet
Executive Summary
Multiple companies are receiving funding or are in discussions with federal agencies about development of rapid assays for Ebola that can be used by patients and health care workers in the field, a top official at the National Institute of Allergy and Infectious Diseases told "The Gray Sheet."